Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist studied extensively for its role in glucose regulation, appetite control, and metabolic health. It closely mimics the body’s own GLP-1 hormone while offering an extended duration of action.

Appetite & weight management

Semaglutide is studied for its ability to:

• Reduce appetite and overall food intake
• Support consistent, sustained weight management
• Slow gastric emptying to promote satiety

Glucose & metabolic regulation

Through GLP-1 receptor activity, Semaglutide is associated with:

• Supporting healthy blood-sugar regulation
• Enhancing glucose-dependent insulin response
• Improving markers of overall metabolic health

GLP-1 receptor signaling

Semaglutide is recognized for:

• Closely mimicking the body’s natural GLP-1 hormone
• An extended half-life suited to once-weekly research protocols